Position in INCY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$142,493
+$41,597 QoQ
Shares Held
1,257
+17.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#669
of 849 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Derivatives in INCY
reported options exposure · as of Jun 30, 2026CallValue
$385,424
CallShares
3,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HUB Investment Partners, LLC holds $3,944,909 across 11 Biotechnology names. INCY ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,079 | $1,296,339 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,140 | $1,063,002 | |
| 3 | SMMT |
Summit Therapeutics Inc.
|
30,197 | $439,970 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,347 | $324,586 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,226 | $229,605 | |
| 6 | INCY |
Incyte Corp
This page
|
1,257 | $142,493 | |
| 7 | GERN |
Geron Corp
|
101,634 | $130,091 | |
| 8 | ALT |
Altimmune, Inc.
|
30,319 | $92,169 |
All Filings in INCY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $142,493 | 1,257 | Shares | Sole | 2026-07-31 | |
| 2026-06-30 | $385,424 | 3,400 | Call | Sole | 2026-07-31 | |
| 2026-03-31 | $100,896 | 1,072 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $291,772 | 3,100 | Call | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||